

Cover Story
Clinical
By Jacquelyn Cobb, Matthew Bin Han Ong and Paul Goldberg
Pragmatica-Lung is shaping up as the clinical trial to watch—not just because of the research question, but because of the way it’s being addressed.
In Brief


Clinical Roundup
Drugs & Targets
NCI Trials


NCI Trials for December 2022
The National Cancer Institute approved the following clinical research studies last month.
Trending Stories
- With Anthony Letai’s appointment, NCI is now under new leadership—just in time for a shutdown
- Anthony G. Letai to be named NCI director
The Dana-Farber and Harvard physician-scientist is an inspired choice, colleagues say - Anthony Letai sworn in as 18th NCI director
- Dana-Farber/Harvard Cancer Center awarded $12M NIH SPORE grant to advance breast cancer research
- Population-based cancer surveillance is a national treasure at risk
- Former NCI official’s nonprofit seeks to tell the stories of cancer patients
Patient Action for Cancer Research aims to show impact of federal research